These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6097091)

  • 21. Dissecting human T cell responses against Bordetella species.
    De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
    J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of Bordetella pertussis by a monoclonal antibody-based colony blot assay.
    Gustafsson B; Askelöf P
    J Clin Microbiol; 1989 Apr; 27(4):628-31. PubMed ID: 2542357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactions between Bordetella pertussis and twenty-eight other bacterial species.
    Høiby N; Hertz JB; Andersen V
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):395-400. PubMed ID: 187010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Polyacrylamide gel disc electrophoretic study of laboratory and freshly isolated strains of Bordetella pertussis and Bordetella parapertussis].
    Samsonova VS; Mamaeva EA; Kondrat'eva AM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):21-4. PubMed ID: 6277109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.
    Li ZM; Brennan MJ; David JL; Carter PH; Cowell JL; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3184-8. PubMed ID: 2903125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point.
    Pagliaccia C; Manetti R; Rappuoli R
    Arch Microbiol; 1997 Nov; 168(5):437-40. PubMed ID: 9325433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Obtaining monoclonal antibodies to Bordetella pertussis antigens].
    Sviridov VV; Kozhevnikova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):67-70. PubMed ID: 2866646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of pertussis toxin in an enzyme linked immunosorbent assay with improved specificity.
    Ibsen P; Heron I
    Biologicals; 1990 Apr; 18(2):123-6. PubMed ID: 2375859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
    Blom J; Heron I; Hendley JO
    APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of two bvg-repressed surface proteins of Bordetella pertussis.
    Stenson TH; Peppler MS
    Infect Immun; 1995 Oct; 63(10):3780-9. PubMed ID: 7558280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.
    Li ZM; Cowell JL; Brennan MJ; Burns DL; Manclark CR
    Infect Immun; 1988 Mar; 56(3):699-702. PubMed ID: 2893776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies.
    Irons LI; Ashworth LA; Wilton-Smith P
    J Gen Microbiol; 1983 Sep; 129(9):2769-78. PubMed ID: 6313862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The property of filamentous hemagglutinin of Bordetella pertussis].
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):331-8. PubMed ID: 1845342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preparation of A purified immunogenic pertactin from B. pertussis.
    El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF
    Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis.
    Di Fabio JL; Caroff M; Karibian D; Richards JC; Perry MB
    FEMS Microbiol Lett; 1992 Oct; 76(3):275-81. PubMed ID: 1427018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis.
    Tang XL; Peppler MS; Irvin RT; Suresh MR
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):752-7. PubMed ID: 15242951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.